1. The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
   Christos Sachpekidis et al, 2021, EJNMMI Research CrossRef
2. Secondary lymphoblastic leukemia occurring 38 months after the primary diagnosis of multiple myeloma: A case report
   Junxun Li et al, 2016, Oncology Letters CrossRef
3. Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature
   Prakash Kharel et al, 2018, Case Reports in Medicine CrossRef
4. Pneumonitis associated with bortezomib in a patient with multiple myeloma
   Taha Ulutan Kars et al, 2023, Journal of Oncology Pharmacy Practice CrossRef
5. Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
   Eric K. Rowinsky et al, 2020, Investigational New Drugs CrossRef
6. COVID-19 Usurps Host Regulatory Networks
   Colleen S. Curran et al, 2020, Frontiers in Pharmacology CrossRef
7. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)
   Adelle S. Jee et al, 2019, Drugs CrossRef
8. Diagnosis and Treatment of AL Amyloidosis
   Giovanni Palladini et al, 2023, Drugs CrossRef
9. Successful renal recovery from multiple myeloma-associated crystalline light chain cast nephropathy and accompanying acute kidney injury with early use of bortezomib-based therapy: a case report and literature review
   Kosuke Miki et al, 2022, CEN Case Reports CrossRef
10. Proteasome dysfunction in alveolar type 2 epithelial cells is associated with acute respiratory distress syndrome
    Sneha Sitaraman et al, 2019, Scientific Reports CrossRef
11. Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib
    Keith J. August et al, 2020, Pediatric Blood & Cancer CrossRef
12. Clinical significance of SIRT3 and inflammatory factors in multiple myeloma patients with bortezomib-induced peripheral neuropathy: a cohort study
    Huiqi Yang et al, 2021, Scandinavian Journal of Clinical and Laboratory Investigation CrossRef